Explain Why Patients Shouldn't Wait to Get Shingrix Instead of Zostavax

December 2016

There's buzz about a new zoster vaccine in the pipeline that's tentatively called Shingrix (SHING-riks).

It probably won't be approved until late 2017 at best.

But it's already making headlines...because it seems to work better than Zostavax to prevent shingles.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote